It is the normal time when Pharma Companies make a Deal,
As they don't need to spend 20 Years on research and development.
They can jump in near the finish line,
And Get it done in no time !!!!
For Example recently Merck & Co
bought out Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion USD (17.18 Billion AUD)
picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and building up its presence in immunology.
https://www.reuters.com/markets/dea...cquire-prometheus-biosciences-wsj-2023-04-16/
Ulcerative colitis and Crohn's disease have a combined market of $17.5 Billion a Year.
BIT in comparison can treat $200 Billion a year markets,
So should be value much higher....IMO....
- Forums
- ASX - By Stock
- BIT
- Ann: Letter to Shareholders
Ann: Letter to Shareholders, page-195
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
3 | 415000 | 0.043 |
3 | 322000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 200000 | 1 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
0.052 | 1527335 | 2 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online